Clinical Trials Directory

Trials / Completed

CompletedNCT05006443

Staging Classification of Severe Tricuspid Regurgitation Using Novel Cardiac Imaging Techniques

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
75 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

The purpose of this research is to assess the severity of tricuspid regurgitation (a disorder in which the tricuspid valve in the heart does not close tight enough) using cardiac magnetic resonance imaging (MRI).

Detailed description

40 patients with moderate or more TR on echocardiography will undergo CMR/MRE with contrast to assess TR severity, and the associated extra-valvular cardiac and liver abnormalities as shown in the flow diagram below. Patients will continue their clinical management by their primary physicians as per the standards of care. 1-year follow up will be conducted via phone to inquire about patient's vital status (dead/alive), symptoms and hospitalizations.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCardiac Magnetic Resonancea non-invasive assessment to determine severity of tricuspid regurgitation

Timeline

Start date
2022-01-14
Primary completion
2023-12-12
Completion
2025-04-30
First posted
2021-08-16
Last updated
2025-05-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05006443. Inclusion in this directory is not an endorsement.

Staging Classification of Severe Tricuspid Regurgitation Using Novel Cardiac Imaging Techniques (NCT05006443) · Clinical Trials Directory